Abstract
Background
The International Headache Society has been offering multiple award opportunities for young researchers and clinicians for many years, with the aim of supporting the development of careers in headache science and medicine.
Methods
In order to assess the outcomes of the International Headache Society award grants, a questionnaire was sent to all previous recipients, investigating a series of aspects related to their work, both during and after award completion.
Results
Of 44 total questionnaires sent, 36 were returned. Eighty-one percent of the recipients reported to have remained in the headache field since the award, half of them held a current academic position and over three-quarters had stayed in contact with the host institution. The totality of questionnaire responders stated that the grant had had a significantly positive impact on their careers.
Conclusions
The International Headache Society grants have assisted many young researchers in building an academic and clinical career in the field of headache, throughout the years.
Keywords: Headache, migraine, International Headache Society, fellowship, grant, funding
Introduction
One of the leading purposes of the International Headache Society (IHS) is to advance headache science and education worldwide. Over the years, the IHS has created and funded a number of training and grant programs, which have been directed at young trainees who are in the process of developing a career in headache research and clinical practice. These awards have typically been undertaken by young investigators who have traveled to large centers with a strong track record of clinical knowledge and research in headache. Different schemes are in place in order to fulfil different purposes, with some awards being directed to clinical and basic scientists alike, and others being offered to neurology trainees or neurologists in order to enhance their clinical skills in headache.
The IHS Fellowship is a one-year award for a total of £50,000, which was first started in 2011. The scope of the fellowship is to support impactful research from young investigators who are within six years of completing their training (either an MD, a PhD, or medical specialty training). This grant scheme is open to applicants from both a basic or clinical background.
The Trainee/Pioneer Program enables young neurologists or neurology trainees from low, lower-middle and upper-middle income countries as defined by the World Bank (1) to visit an international headache center for up to 12 weeks. The award, which totals $10,000 per recipient, has the scope to actively increase knowledge on headache disorders and specialized headache management. It is also intended to spread this knowledge to the recipients’ home countries, for the ultimate benefit of local headache patients.
The Short-Stay Scholarship is a clinical training period of up to 6 weeks at an international headache center, which was first awarded in 2013. In years corresponding with the International Headache Congress (IHC), the program is held in the same region as the congress, and winning scholars are also funded to attend this. When taking place in alternate years with respect to IHC, the scholars receive funding to attend a regional headache conference. Funding for this scheme has been €5,000 up to 2016 and €6,000 from 2017.
Finally, the Allied Specialties Scholarship, which was pioneered in 2021, facilitates clinical training or a research project through a scholarship directed at specialists in fields that are allied to headache medicine, such as nurses and physiotherapists.
Methods
With the aim of assessing the outcomes of the different grant schemes, a structured questionnaire was sent via email on behalf of the IHS Education Committee, Science and Research Committee, and Junior’s Group, to all awardees of the above-mentioned grants (Fellowship, Trainee Program and Short-Stay Scholarship). All questionnaire recipients had obtained a grant between 2011 to 2020 and all had been actively completed.
The questionnaire asked for the recipient’s personal details (name, nationality, current position and institution, email address) and details of the grant (dates, host institution name and mentor, title of study). It also included six yes/no questions aimed at understanding the impact the grant had on the recipients’ careers and their ongoing presence in the headache field. These were: 1) Are you still working in the headache/neurology field?; 2) Are you a member of your national headache society?; 3) Are you a member of any IHS or national society Committees/Special Interest Groups?; 4) Have you published any peer-review articles that were related to your stay?; 5) Are you still in contact and collaborating with the headache center you visited?; 6) How have you benefited from the IHS grant? If the recipient answered yes, they were further asked to elaborate details in their answer.
Results
The turnover for questionnaire completion was high, over 80% in all three groups and the main results of the questionnaire assessment have been summarized in Table 1.
Table 1.
Results from the questionnaire. Table shows total numbers and in parenthesis % of completers.
| Fellowship | Trainee program | Short-stay scholarship | Total | |
|---|---|---|---|---|
| Total awarded | 20 | 12 | 24 | 56 |
| Total questionnaire recipients | 15 | 10 | 19 | 44 |
| Total completed | 13 (87) | 8 (80) | 15 (79) | 36 (82) |
| Currently in academic position | 10 (77) | 3 (38) | 6 (40) | 19 (53) |
| Currently actively working in headache | 8 (62) | 8 (100) | 13 (87) | 29 (81) |
| Currently member of national headache society | 4 (33) | 7 (88) | 13 (87) | 24 (69) |
| Currently member of IHS or national society committees | 4 (33) | 5 (63) | 9 (60) | 18 (51) |
| 1st author publications from fellowship | 10 (83) | 4 (50) | 5 (33) | 19 (54) |
| Currently in contact or collaborating with host institution | 11 (85) | 6 (75) | 11 (73) | 28 (78) |
| Positively benefitted from grant | 13 (100) | 8 (100) | 15 (100) | 36 (100) |
With regards to IHS Fellowships, of the total 20 awarded since the start of the scheme, five are currently ongoing. The remaining 15 recipients were sent the questionnaires and 13 completed it (one recipient was not contactable, but information regarding the grant outcome was delivered by a former mentor). Of these, currently 77% have obtained an academic position, which in over half the cases involves headache. Ten former IHS fellows have published at least one first author paper in collaboration with the host institution, and several of these publications have been accepted in high impact journals (2 –11). Figure 1 shows the country of origin and of destination of all recipients of the IHS Fellowship.
Figure 1.
World map showing country of origin and final destination (i.e. host institution) of the twenty recipients of the IHS fellowship, from its start in 2011 to the present day.
The Trainee Program has been awarded to 12 people, and two of these awards are currently ongoing. Eight of the remaining ten recipients who completed this scheme responded to the questionnaire. Of these, all of them have remained active in the headache field, with at least five running independent headache clinics in their country of origin. The large majority of former trainees have been participating in the activities of the IHS or their local headache society in the country of origin, when these exist. Even if this training scheme is mostly clinical in nature and shorter than a fellowship, relevant first author publications have arisen from it as well (12,13).
A total of 24 Short-Stay Scholarships have been awarded over the years; five of these were originally awarded in 2020 and had to be rescheduled for the current year due to the COVID-19 pandemic. Of the 19 recipients who were contacted, 15 completed the questionnaire. A high proportion of them are still active in the headache field and the large majority has kept some form of contact with the host institution, usually in the context of discussions of complex clinical cases or for scientific collaborations. Importantly, two scholars have been instrumental in setting up a national headache society in their home country, upon returning from the program.
Finally, two Allied Specialties Scholarships were awarded in 2021 but deferred to 2022 due to the COVID-19 pandemic. Therefore, questionnaires were not sent out to these recipients.
Figure 2 shows the origin and destination of recipients for the Trainee Program, Short-Stay Scholarships and Allied Specialties Scholarships, and Table 2 summarizes the countries of origin and destination for the totality of awards.
Figure 2.
World map showing country of origin and final destination (i.e. host institution) of the recipients of the trainee programme (yellow line), the short stay scholarship (blue line) and allied specialties programme (grey line).
Table 2.
Countries of origin and destination for all grants, per year of award.
| Type of award | Year awarded | City and country of origin | Institution and country of destination |
|---|---|---|---|
| Fellowship | 2021 | Curitiba, Brazil | Vall d'Hebron Institute of Research, Barcelona, Spain |
| Phoenix, AZ, USA | Stanford University, Stanford, CA, USA | ||
| Toulouse, France | Danish Headache Center, Glostrup, Denmark | ||
| 2020 | Athens, Greece | Danish Headache Center, Glostrup, Denmark | |
| Queretaro, Mexico | King’s College London, UK | ||
| 2019 | Leiden, Netherlands | Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA | |
| Birmingham, UK | Danish Headache Center, Glostrup, Denmark | ||
| 2018 | Liege, Belgium | King’s College London, UK | |
| Ankara, Turkey | Leiden University Medical Center, Netherlands | ||
| 2017 | Leiden, Netherlands | Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA | |
| Taipei, Taiwan | Universitäts-Krankenhaus Eppendorf (UKE), Hamburg, Germany | ||
| 2016 | Ankara, Turkey | Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA | |
| 2015 | Glostrup, Denmark | Erasmus Medical Center, Rotterdam, Netherlands | |
| 2014 | Barcelona, Spain | King’s College London, UK | |
| 2013 | Ankara, Turkey | UCSD, San Diego, CA, USA | |
| 2012 | Tehran, Iran | Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA | |
| 2012 | Leiden, Netherlands | Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA | |
| 2012 | Halifax, Canada | University of Arizona and Mayo Clinic, AZ, USA | |
| 2011 | Glostrup, Denmark | UCLA School of Medicine, Los Angeles, CA, USA | |
| 2011 | Kyiv, Ukraine | University of Utah, Salt Lake City, UT, USA | |
| Trainee Program | 2020 | Medellin, Colombia | São Paulo Headache Center, Sao Paolo, Brazil |
| Bangkruai, Thailand | King's College London, UK | ||
| Serdang, Malaysia | King's College London, UK | ||
| 2019 | Tbilisi, Georgia | Danish Headache Centre, Glostrup, Denmark | |
| 2018 | Tbilisi, Georgia | University of Duisburg-Essen, Essen, Germany | |
| Cairo, Egypt | King’s College London, UK | ||
| 2017 | Arequipa, Peru | King’s College London, UK | |
| 2016 | Kharkiv, Ukraine | Mayo Clinic, Scottsdale, AZ, USA | |
| 2015 | Bishkek, Kygrystan | King’s College London, UK | |
| 2014 | Kutaisi, Georgia | Danish Headache Centre, Glostrup, Denmark | |
| 2014 | Bangkok, Thailand | Jefferson Headache Centre, Philadelphia, PA, USA | |
| 2013 | Dakar, Senegal | CHR Citadelle, Liege, Belgium | |
| Short-Stay Scholarship | 2020 | Ribeirao Preto, Brazil | Guy's and St Thomas, London, UK |
| Isfahan, Iran | Danish Headache Center, Glostrup, Denmark | ||
| Kazan, Russia | Danish Headache Center, Glostrup, Denmark | ||
| Zanjan, Iran | King’s College London, UK | ||
| Yereva, Armenia | Danish Headache Center, Glostrup, Denmark/Hull Royal Infirmary, Hull, UK | ||
| 2019 | Patna, India | Tallaght Hospital, Dublin, Ireland | |
| Coimbatore, India | Beaumont Hospital, Dublin, Ireland | ||
| Belgrade, Serbia | Mater Misericordiae University Hospital, Dublin, Ireland | ||
| 2018 | Bogota, Colombia | Vall d'Hebron University Hospital, Barcelona, Spain | |
| Ulaanbaatar, Mongolia | Pediatric Hospital Bambino Gesu, Rome, Italy | ||
| Kharkiv, Ukraine | Pediatric Hospital Bambino Gesu, Rome, Italy | ||
| 2017 | Bishkek, Kygrystan | University of Western Ontario, London, Canada | |
| Tbilisi, Georgia | Hamilton Canadian Headache Observership, Toronto, Canada | ||
| Bishkek, Kygrystan | University of Calgary, Canada | ||
| 2016 | New Deilhi, India | National Hospitals for Neurology and Neurosurgery, London, UK | |
| Isfahan, Iran | Department of Neurology, Hull Royal Infirmary, Hull, UK | ||
| Bangkok, Thailand | King’s College London & Pain and Neuromodulation Centre, London, UK | ||
| 2015 | Cordoba, Argentina | Hospital Clínico Universitario, Valencia, Spain | |
| Medellin, Colombia | Hospital Ruber Internacional, Madrid, Spain | ||
| Bogota, Colombia | University Hospital Central de Asturias, Oviedo, Spain | ||
| 2014 | Chisinau, Moldova | Danish Headache Centre, Glostrup, Denmark | |
| 2013 | Yangon, Myanmar | Mayo Clinic, Scottsdale, AZ, USA | |
| Chisinau, Moldova | Albert Einstein College of Medicine, New York, NY, USA | ||
| Addis Ababa, Ethiopia | Stanford Headache Program, Stanford, CA, USA |
Considering all grants schemes together, a total of 29 awarded recipients (81% of questionnaire completers) have remained in the headache field, however, this was much higher for the trainee program (100%) than for the fellowship program (62%). Looking at individual cases, the main reason for former fellows leaving the field was due to the difficulty in pursuing a scientific career in academia altogether, particularly in the case of those with a basic science background. In the case of clinicians, the headache field was mostly abandoned while undertaking a neurology residency program.
The majority of grant recipients have remained in contact or in active collaboration with their host institution; two have since stayed in the same laboratory/research group following the end of the award period, and another three have stayed in the country where the fellowship took place for further career opportunities.
Importantly, all the completers of the questionnaire, regardless of the type of award received, judged it to have positively impacted and shaped their careers. The awards were explained to have helped them in several ways through their careers, from increasing knowledge to allowing their growth as scientists and researchers. By opening further funding and collaboration opportunities, the grants were described as having directly determined the work of the awardees, their current lines of research as well as relevant academic and scientific positions obtained after the grant. In several cases, the grant was even instrumental in shaping life choices such as changing country of residence after the end of the award.
A limitation of our study is certainly the small sample size due to the fact that the awards are limited in number because of monetary resources, and have started relatively recently. Further, their duration can be long, with several recipients currently involved in a grant and being thus unable to take part in the questionnaire. Repeating this study in a few years might help address these issues and provide further information on the long-term effects of the awards. A further source of bias resides in the fact that the awardees who benefitted the most might have been more inclined to respond. Finally, it is important to acknowledge that, although these schemes have benefitted people from a large variety of countries, they cannot fully counteract the inequality in opportunities between different regions of the world.
In conclusion, this short questionnaire survey helped to consolidate the importance of grant schemes created by the IHS in order to promote the careers of young scientists and clinicians in the field of headache. It also shows that improvement needs to be made for future opportunities, particularly in facilitating basic scientists and clinicians who struggle to remain in the academic field. Some possibilities could include the addition of targeted training programs focused on academic development, the creation of specific networking events to connect past awardees with newly awarded recipients, and finally a continuation of support from the host institutions to former grant holders through virtual mentoring programs.
Article highlights
The IHS grants have been instrumental in allowing young neurologists and researchers in building an academic and clinical career in the field of headache, throughout the years.
Acknowledgements
The authors would like to thank all of the grant recipients who took the time to complete the survey, and Carol Taylor for her invaluable help.
Footnotes
Declaration of conflicting interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The authors received no financial support for the research, authorship, and/or publication of this article.
ORCID iDs
Francesca Puledda https://orcid.org/0000-0002-1933-4049
Shuu-Jiun Wang https://orcid.org/0000-0001-5179-5358
Hans-Christoph Diener https://orcid.org/0000-0002-6556-8612
Henrik Winther Schytz https://orcid.org/0000-0002-6262-2986
References
- 1. World Bank Country and Lending Groups , The World Bank. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed 20 April 2022).
- 2.Mulder IA, Li M, de Vries T, et al. Anti-migraine calcitonin gene-related peptide receptor antagonists worsen cerebral ischemic outcome in mice. Ann Neurol 2020; 88: 771–784. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Peng KP, Basedau H, Oppermann T, et al. Trigeminal sensory modulatory effects of galcanezumab and clinical response prediction. Pain Epub date 14 Feb 2022. doi: 10.1097/j.pain.0000000000002614. [DOI] [PubMed] [Google Scholar]
- 4.Vuralli D, Arslan B, Topa E, et al. Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition. J Headache Pain 2022; 23: 36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Haanes KA, Labastida-Ramírez A, Blixt FW, et al. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models. Cephalalgia 2019; 39: 1421–1434. [DOI] [PubMed] [Google Scholar]
- 6.Vila-Pueyo M, Strother LC, Kefel M, et al. Divergent influences of the locus coeruleus on migraine pathophysiology. Pain 2019; 160: 385–394. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kılıç K, Desjardins M, Tang J, et al. Chronic cranial windows for long term multimodal neurovascular imaging in mice. Front Physiol 2021; 11: 612678. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sadeghian H, Lacoste B, Qin T, et al. Spreading depolarizations trigger caveolin-1-dependent endothelial transcytosis. Ann Neurol 2018; 84: 409–423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Green AL, Gu P, De Felice M, et al. Increased susceptibility to cortical spreading depression in an animal model of medication-overuse headache. Cephalalgia 2014; 34: 594–604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hansen JM, Baca SM, Vanvalkenburgh P, et al. Distinctive anatomical and physiological features of migraine aura revealed by 18 years of recording. Brain 2013; 136: 3589–3595. [DOI] [PubMed] [Google Scholar]
- 11.Bogdanov VB, Middleton NA, Theriot JJ, et al. Susceptibility of primary sensory cortex to spreading depolarizations. J Neurosci 2016; 36: 4733–4743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Gvantseladze K, Do TP, Hansen JM, et al. The stereotypical image of a person with migraine according to mass media. Headache 2020; 60: 1465–1471. [DOI] [PubMed] [Google Scholar]
- 13.Vongvaivanich K, Lertakyamanee P, Silberstein SD, et al. Late-life migraine accompaniments: A narrative review. Cephalalgia 2015; 35: 894–911. [DOI] [PubMed] [Google Scholar]